2 Result: LivaNova
Q2 Earnings Breakthrough: LivaNova and Owens Corning Exceed Forecasts
July 26th, 2023
LivaNova PLC (Nasdaq: LIVN) reported a robust second-quarter 2023 adjusted earnings per share (EPS) of $0.78, surpassing the consensus estimate of $0.54. The company also raised its full-year 2023 guidance for adjusted EPS to a range of $2.5. Read more
Lucintel Forecasts Neuroprosthetic Market to grow at a CAGR of 12% from 2019 to 2024
December 09th, 2021
Dallas, TX / CRWE PRESS RELEASE / Dec. 9, 2021 - According to the recent study the Neuroprosthetic Market is projected to grow at a CAGR of 12% from 2019 to 2024. Growth in this market is primarily driven by increasing number of patients sufferi. Read more
Want To Find Some News?
News By Industries
Recent Post
-
December 05th, 2025
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025
Member Login